DocDollars

Tg Therapeutics, Inc.

NC · United States · Reporting entity ID 100000961857

Total reported 2019–2025
$51.1M
#173 of 2,960 reporting companies — 0.1% of all reported industry payments
$15.1M in general payments across 39,864 records, plus $35.9M in research funding across 9,437 records.

How it breaks down

General payments $15,129,979
Research funding $35,948,242

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tg Therapeutics, Inc. reported $51.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #173 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 39,864 general payment records and 9,437 research records were filed.

Common questions about Tg Therapeutics, Inc.

How much has Tg Therapeutics, Inc. paid US doctors?

Tg Therapeutics, Inc. reported $51,078,221 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $15,129,979 in general payments, $35,948,242 in research funding.

How does Tg Therapeutics, Inc. rank among drug and device companies?

It ranks #173 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Tg Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.